MétaCan
Menu
Back to cohort
Record W4407418836 · doi:10.1002/alz.14579

SSRIs reduce plasma tau and restore dorsal raphe metabolism in Alzheimer's disease

2025· article· en· W4407418836 on OpenAlexafffund
Dylan J. Terstege, Shaista Jabeen, Liisa A.M. Galea, Jonathan R. Epp, Derya Sargin

Bibliographic record

VenueAlzheimer s & Dementia · 2025
Typearticle
Languageen
FieldMedicine
TopicAlzheimer's disease research and treatments
Canadian institutionsUniversity of TorontoCentre for Addiction and Mental HealthAlberta Children's HospitalHotchkiss Brain InstituteUniversity of Calgary
FundersNational Institute of Biomedical Imaging and BioengineeringNational Institute on AgingAlberta Children's Hospital Research InstituteNational Institutes of HealthAlzheimer Society Research ProgramAlzheimer's SocietyNatural Sciences and Engineering Research Council of CanadaFondation Brain CanadaAlzheimer's Disease Neuroimaging InitiativeAlzheimer SocietyU.S. Department of Defense
KeywordsSerotonergicDorsal raphe nucleusCognitive declineNeurodegenerationInternal medicineNeuroscienceRaphe nucleiPsychologyBiomarkerMedicineTauopathySerotoninEndocrinologyDiseasePathologyDementiaBiology

Abstract

fetched live from OpenAlex

INTRODUCTION: Tau pathology impacts neurodegeneration and cognitive decline in Alzheimer's disease (AD), with the dorsal raphe nucleus (DRN) being among the brain regions showing the earliest tau pathology. As a serotonergic hub, DRN activity is altered by selective serotonin reuptake inhibitors (SSRIs), which also have variable effects on cognitive decline and pathology in AD. METHODS: F-fluorodeoxyglucose positron emission tomography and plasma biomarker data to study the effects of SSRIs on tau pathology, cognitive decline, and DRN metabolism. RESULTS: Plasma phosphorylated tau 181 (p-tau181) was lower with SSRI use. The effect of SSRIs on cognition varied by cognitive assessment. The DRN was hypometabolic in AD patients relative to healthy controls; however, SSRI use restored the metabolic activity of this region in AD patients. DISCUSSION: Long-term SSRI use may reduce the pathological presentation of AD but has variable effects on cognitive performance. HIGHLIGHTS: Tau pathology spreads throughout the brain during AD pathogenesis. The DRN is among the first regions to develop tau pathology during this process. SSRI use restores the metabolic activity of the DRN and reduces plasma p-tau181.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.007

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.027
GPT teacher head0.316
Teacher spread0.289 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations13
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueAlzheimer s & DementiaSame topicAlzheimer's disease research and treatmentsFrench-language works237,207